Potentiation of novel porphyrin based photodynamic therapy against colon cancer with low dose doxorubicin and elucidating the molecular signalling pathways responsible for relapse.

[1]  R. Pandey,et al.  Photodynamic Therapy in Combination with Doxorubicin Is Superior to Monotherapy for the Treatment of Lung Cancer , 2022, Biomedicines.

[2]  E. Ranieri,et al.  The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review , 2021, Cancers.

[3]  Xiaozhuo Chen,et al.  Cancer stem cells, epithelial-mesenchymal transition, ATP and their roles in drug resistance in cancer , 2021, Cancer drug resistance.

[4]  W. Duan,et al.  The inhibition of ABCB1/MDR1 or ABCG2/BCRP enables doxorubicin to eliminate liver cancer stem cells , 2021, Scientific Reports.

[5]  Liaotian Peng,et al.  Heat Shock Protein 90 Triggers Multi-Drug Resistance of Ovarian Cancer via AKT/GSK3β/β-Catenin Signaling , 2021, Frontiers in Oncology.

[6]  T. Kondo,et al.  Evaluation of the correlation between porphyrin accumulation in cancer cells and functional positions for application as a drug carrier , 2021, Scientific Reports.

[7]  G. Berx,et al.  Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target , 2021, Cells Tissues Organs.

[8]  P. Basak,et al.  Conducting Nanofibers: Diagonal Scrolling of 2D Nanosheets into 1D Nanostructures via In Situ Self-Assembly , 2020, ACS Applied Electronic Materials.

[9]  Z. Kianmehr,et al.  Synergistic effect of photodynamic treatment and doxorubicin on triple negative breast cancer cells , 2020, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[10]  yang-xin fu,et al.  β-Catenin regulates tumor-derived PD-L1 , 2020, The Journal of experimental medicine.

[11]  Katsuaki Sato,et al.  Photodynamic Therapy Using a Novel Phosphorus Tetraphenylporphyrin Induces an Anticancer Effect via Bax/Bcl-xL-related Mitochondrial Apoptosis in Biliary Cancer Cells , 2020, Acta histochemica et cytochemica.

[12]  Xi C. He,et al.  Overcoming Wnt–β-catenin dependent anticancer therapy resistance in leukaemia stem cells , 2020, Nature Cell Biology.

[13]  Michael R Hamblin,et al.  Photodynamic therapy using zinc phthalocyanine in low dose of diode laser combined with doxorubicin is a synergistic combination therapy for human SK-MEL-3 melanoma cells. , 2019, Photodiagnosis and photodynamic therapy.

[14]  P. Tonellato,et al.  A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability , 2019, Molecular Cancer Research.

[15]  A. Isaacs,et al.  Mechanisms of doxorubicin-induced drug resistance and drug resistant tumour growth in a murine breast tumour model , 2019, BMC Cancer.

[16]  Xiaomo Wu,et al.  Application of PD-1 Blockade in Cancer Immunotherapy , 2019, Computational and structural biotechnology journal.

[17]  L. Giribabu,et al.  Novel Amphiphilic G-Quadruplex Binding Synthetic Derivative of TMPyP4 and Its Effect on Cancer Cell Proliferation and Apoptosis Induction. , 2018, Biochemistry.

[18]  Hanchen Xu,et al.  Drug resistance and new therapies in colorectal cancer , 2018, World journal of gastroenterology.

[19]  Jian Zhang,et al.  Doxorubicin resistance induces IL6 activation in the colon cancer cell line LS180 , 2018, Oncology letters.

[20]  S. C. Karunakaran,et al.  In Vitro and In Vivo Demonstration of Human-Ovarian-Cancer Necrosis through a Water-Soluble and Near-Infrared-Absorbing Chlorin. , 2018, Journal of medicinal chemistry.

[21]  Cheng-Ta Yang,et al.  Stomatin-like protein 2 regulates survivin expression in non-small cell lung cancer cells through β-catenin signaling pathway , 2018, Cell Death & Disease.

[22]  Vicky M. Avery,et al.  Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins , 2018, BMC Cancer.

[23]  H. Abrahamse,et al.  In vitro combined effect of Doxorubicin and sulfonated zinc Phthalocyanine–mediated photodynamic therapy on MCF-7 breast cancer cells , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[24]  Bin Chen,et al.  Targeting Phosphatidylinositol 3-Kinase Signaling Pathway for Therapeutic Enhancement of Vascular-Targeted Photodynamic Therapy , 2017, Molecular Cancer Therapeutics.

[25]  Lingamallu Giribabu,et al.  Photodynamic Therapy: Past, Present and Future. , 2017, Chemical record.

[26]  Cláudia T. Arranja,et al.  Photophysical Characterization and in Vitro Phototoxicity Evaluation of 5,10,15,20-Tetra(quinolin-2-yl)porphyrin as a Potential Sensitizer for Photodynamic Therapy , 2016, Molecules.

[27]  Juan Wang,et al.  Hypoxia regulates ABCG2 activity through the activivation of ERK1/2/HIF-1α and contributes to chemoresistance in pancreatic cancer cells , 2016, Cancer biology & therapy.

[28]  Bing Liu,et al.  Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity , 2015, Cancer Cell International.

[29]  Zhengze Yu,et al.  A Near-Infrared Triggered Nanophotosensitizer Inducing Domino Effect on Mitochondrial Reactive Oxygen Species Burst for Cancer Therapy. , 2015, ACS nano.

[30]  Michael R Hamblin,et al.  Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies , 2015, Cancer and Metastasis Reviews.

[31]  M. Kwak,et al.  The c-MET/PI3K Signaling Is Associated with Cancer Resistance to Doxorubicin and Photodynamic Therapy by Elevating BCRP/ABCG2 Expression , 2015, Molecular Pharmacology.

[32]  Radim Kučera,et al.  Far-red-absorbing cationic phthalocyanine photosensitizers: synthesis and evaluation of the photodynamic anticancer activity and the mode of cell death induction. , 2015, Journal of medicinal chemistry.

[33]  N. Baldini,et al.  Involvement of HIF-1α activation in the doxorubicin resistance of human osteosarcoma cells. , 2014, Oncology reports.

[34]  J. Castle,et al.  Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma , 2014, BMC Genomics.

[35]  F. Zeman,et al.  Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry , 2013, Breast Cancer Research and Treatment.

[36]  مهرداد پورجعفر,et al.  بررسی اثر تجویز خوراکی آیور مکتین بر برخی پارامترهای هماتولوژی و بیوشیمیایی خون الاغ (اکووس آسینوس) , 2013 .

[37]  R. Battafarano,et al.  Loss of p53, rather than beta-catenin overexpression, induces survivin-mediated resistance to apoptosis in an esophageal cancer cell line. , 2010, The Journal of thoracic and cardiovascular surgery.

[38]  Patrycja Nowak-Sliwinska,et al.  In vitro and in vivo photocytotoxicity of boron dipyrromethene derivatives for photodynamic therapy. , 2010, Journal of medicinal chemistry.

[39]  C. Gomer,et al.  Targeting the 90 kDa heat shock protein improves photodynamic therapy. , 2010, Cancer letters.

[40]  N. Lange,et al.  Combination of photodynamic therapy with anti-cancer agents. , 2008, Current medicinal chemistry.

[41]  D. Kessel,et al.  Apoptosis and Autophagy After Mitochondrial or Endoplasmic Reticulum Photodamage † , 2007, Photochemistry and photobiology.

[42]  C. M. Yow,et al.  Study of the efficacy and mechanism of ALA‐mediated photodynamic therapy on human hepatocellular carcinoma cell , 2007, Liver international : official journal of the International Association for the Study of the Liver.

[43]  J. Usuda,et al.  Lysosomal cathepsin initiates apoptosis, which is regulated by photodamage to Bcl-2 at mitochondria in photodynamic therapy using a novel photosensitizer, ATX-s10 (Na). , 2006, International journal of oncology.

[44]  M. Oshimura,et al.  PI3K-Akt pathway: Its functions and alterations in human cancer , 2004, Apoptosis.

[45]  J. Didziapetriene,et al.  Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo , 2005, Cancer Chemotherapy and Pharmacology.

[46]  J. Schuetz,et al.  The Stem Cell Marker Bcrp/ABCG2 Enhances Hypoxic Cell Survival through Interactions with Heme* , 2004, Journal of Biological Chemistry.

[47]  C. Whiteford,et al.  Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage , 2004, Oncogene.

[48]  J. Berzofsky,et al.  Transforming Growth Factor-β Production and Myeloid Cells Are an Effector Mechanism through Which CD1d-restricted T Cells Block Cytotoxic T Lymphocyte–mediated Tumor Immunosurveillance , 2003, The Journal of Experimental Medicine.

[49]  P. Mróz,et al.  Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[50]  P. Dennis,et al.  Activation of the PI3K/Akt pathway and chemotherapeutic resistance. , 2002, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[51]  Jitsuo Usuda,et al.  Promotion of Photodynamic Therapy-Induced Apoptosis by the Mitochondrial Protein Smac/DIABLO: Dependence on Bax¶ , 2002, Photochemistry and photobiology.

[52]  D. Kessel,et al.  Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves bid cleavage , 2002, Cell Death and Differentiation.

[53]  J. R. Perussi,et al.  The effect of porphyrins on normal and transformed mouse cell lines in the presence of visible light. , 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[54]  D. Kessel,et al.  Determinants of the Apoptotic Response to Lysosomal Photodamage , 2000, Photochemistry and photobiology.

[55]  K. Kinzler,et al.  Identification and classification of p53-regulated genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[56]  B. McManus,et al.  Bcl-2 overexpression blocks caspase activation and downstream apoptotic events instigated by photodynamic therapy , 1999, British Journal of Cancer.

[57]  K. Sakaguchi,et al.  DNA damage activates p53 through a phosphorylation-acetylation cascade. , 1998, Genes & development.

[58]  A. M. del C. Batlle,et al.  Enhancement of aminolevulinic acid based photodynamic therapy by adriamycin. , 1997, Cancer letters.

[59]  L. Kedes,et al.  Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[60]  C. Geroni,et al.  Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin. , 1986, British Journal of Cancer.